Moderna Analysts Plan Reckoning After Valuation Declines

(Bloomberg) -- Moderna Inc.’s shares have lost more than a third of their value since a lofty IPO pricetag left some analysts bewildered. This week, Wall Street will look at prospects for the compa...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.